Robert Gonzalez
Family Medicine · Wichita, KSNPI 1457363434
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $650 and has fallen 97.6% since, to $16 in 2023.
Across 99 payments — averaging $12.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$176
- Novo Nordisk$174
- AbbVie$165
- Johnson & Johnson$153
- Bayer$84
- Boehringer Ingelheim$79
- plus $416 from 18 others
What the payments were for
- Food & beverage$1,247100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 12 | $176 |
| Novo Nordisk | 24 | $174 |
| AbbVie | 10 | $165 |
| Johnson & Johnson | 13 | $153 |
| Bayer | 4 | $84 |
| Boehringer Ingelheim | 6 | $79 |
| Amarin Pharma, Inc. | 6 | $74 |
| Eisai Inc. | 3 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Nevro Corp. | 1 | $34 |
| Daiichi Sankyo Inc. | 2 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $24 |
| Biohaven Pharmaceuticals, Inc. | 2 | $23 |
| Medtronic | 1 | $20 |
| Radius Health, Inc. | 1 | $16 |
| Electromed, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| Pfizer | 1 | $12 |
| GSK | 1 | $12 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
| Abbott | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $11 |
How this compares
$1,247 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tolterodine Tartrate | 13 | $2,179 |
| Metolazone | 14 | $313 |
| Pantoprazole Sodium | 13 | $101 |
| Atorvastatin Calcium | 14 | $82 |
| ClopidogrelClopidogrel Bisulfate | 13 | $76 |
| Carvedilol | 13 | $57 |
| Meloxicam | 13 | $50 |
| Furosemide | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Wichita
- Mila MeansWichita$241K
- Cole GillenwaterWichita$62K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
- Joseph SackWichita$21K
- Scott StringfieldWichita$20K
- Mark LeikerWichita$20K
- Paul DavisWichita$18K
- Tara NeilWichita$16K
- William SimonWichita$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.